A novel herbal combination ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with letrozole-induced polycystic ovary syndrome

Abstract

Objective: To investigate the potential activity of novel herbal combination and novel herbal formulation (syrup) in female Sprague Dawley rats with letrozole-induced polycystic ovary syndrome (PCOS).

Methods: Forty-two rats were randomly divided into seven groups with six rats in each group. Group 1 received 0.5% carboxy methylcellulose orally for 37 days and served as the normal control group. Group 2 was orally administered with letrozole of 1 mg/kg for 21 days and served as the PCOS induction group without treatment. Group 3 to 7 were administered with letrozole of 1 mg/kg for 21 days orally to induce PCOS, and then respectively received clomiphene citrate at 1 mg/kg, 100 and 200 mg/kg of novel herbal combination, 200 mg/kg of novel herbal formulation (syrup), and 400 mg/kg of marketed formulation of Pushyanuga churna, once daily for 15 days. Effects of the novel herbal combination and its syrup formulation were evaluated on the hormonal profile, the levels of antioxidants, the lipid profile and on the ovarian morphology, using letrozole-induced PCOS model in rats.

Results: Letrozole caused alterations in hormonal levels and lipid levels similar to PCOS and ovarian histology showed presence of ovarian cysts confirming the induction of PCOS in rats. On treatment with the novel herbal combination and its syrup formulation in PCOS-induced rats, the altered hormonal and lipid profiles showed significant recovery to normal levels. Ovarian histology confirmed the restoration of folliculogenesis in the PCOS-induced rats. The treatment with the syrup formulation of novel herbal combination was found to be more effective than novel herbal combination and showed better recovery in various parameters evaluated. The results of the study, however, suggested that treatment with novel herbal combination and its syrup formulation provided minimal protection against oxidative stress caused due to the induction of PCOS.

Conclusions: The integrated approach for management of PCOS is to counterbalance the limitations associated with modern therapy. Both the novel herbal combination and the syrup formulation of novel herbal combination show efficacy in the management of PCOS in rats and restore folliculogenesis in the ovary. The syrup formulation of novel herbal combination is most effective in the management of PCOS and shows potential to be developed as an adjuvant therapeutic agent.

Keywords

Polycystic ovarian syndrome / Polyherbal combination / Letrozole / Pushyanuga churna / Clomiphene citrate / Histopathology / Biochemical / Herbal

Conflict of interest statement

The authors declare no conflict of interest.

Funding

This study was supported by DST-SERB, Government of India via sanction No. EMR/2017/001106.

Authors’ contributions

Sunita Shailajan is Principal Investigator and Sasikumar Kumar is Co-Principal Investigator in the project. Yugandhara Patil and Swati Singh are Project Fellows. Yugandhara Patil and Swati Singh performed the experiment and submitted the data for analysis. Sasikumar Menon was involved in the designing and interpretation of animal studies while Sunita Shailajan was involved in designing the formulation composition, chromatography and interpretation of phytochemical studies. All authors were involved in the preparation of manuscript.

References

[1] Ganie MA, Rashid A, Sahu D, Nisar S, Wani I, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study. Int J Gynecol Obstet 2020; 149(2):231-236.

[2] Corte LD, Foreste V, Barra F, Gustavino C, Alessandri F, Centurioni MG, et al. Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opin Invest Drugs 2020; 29(8):819830.

[3] Mukherjee N. Polycystic ovary syndrome (PCOS) symptoms, causes and treatments: A review. Int J Sci Res 2018; 9(7):1949-1958.

[4] Tiwari N, Pasrija S, Jain S. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2019; 234:149-154.

[5] Reddy PS, Begum N, Mutha S, Bakshi V. Beneficial effect of curcumin in letrozole induced polcystic ovary syndrome. Asian Pac J Reprod 2016; 5(2):116-122.

[6] Demirel MA, Ilhan M, Suntar I, Keles H, Akkol E. Activity of Corylus avellana seed oil in letrozole-induced polycystic ovary syndrome model in rats. Braz J Pharm 2016; 26(1):83-86.

[7] Brenda MP. An investigation of treatments for the prevention of metabolic complications for women suffering from polycystic ovarian syndrome: Diet, exercise, weight reduction and herbal remedies. PhD thesis. 2020 California Dominican University of California. https://doi.org/10.33015/dominican.edu/2020.NURS.ST.13.

[8] Johansson J, Stener-Victorin E. Polycystic ovary syndrome: Effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med 2013; 2013: 762615. doi: 10.1155/2013/762615.

[9] Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil Soc J 2011; 16:19-37.

[10] Solorzano B, Beller J, Collinis J, McCarteny C, Marshell J. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 2012; 77(4):332-337.

[11] Tsutsumi R, Webster N. GnRH pulsatility, the pituitary response and reproductive. Endocrinol J 2009; 56(6):729-737.

[12] Amer SAK. Polycystic ovarian syndrome: Diagnosis and management of related infertility. Obstet Gynecol Reprod Med 2009; 19(10):263-270.

[13] Choi JH, Jang M, Kim E, Lee M, Park K, Kim S, et al. Korean Red Ginseng alleviates dehydro-epiandrosterone-induced polycystic ovarian syndrome in rats via its antiinflammatory and antioxidant activities. J Ginseng Res 2020; 44(6):790-798. doi: 10.1016/j.jgr.2019.08.007.

[14] Poddar S, Sarkar T, Choudhary S, Chatterjee S. Indian traditional medicinal plants: A concise review. Int J Botany Stud 2020; 5(5):174190.

[15] Shailajan S. Evidence based assessment of Wild Himalayan Berry (Myrica esculenta Buch) in the management of polycystic ovarian syndrome. In:Proceeding of 8th International Conference on Nutrition, Food Science and Technology, December 9-10, 2019, Dubai, UAE. J Food Sci Nutr. 2019; 2:19.

[16] Jadhav M, Menon S, Shailajan S. Anti-androgenic effect of Symplocos racemosa Roxb. against letrozole induced polycystic ovary using rat model. J Coast Life Med 2013; 1(4):306-311.

[17] Jadhav M, Menon S, Shailajan S. In vivo evaluation of Mimosa pudica Linn. in the management of polycystic ovary using rat model. Int J Appl Biol Pharm Technol 2013; 4(1):285-292.

[18] Adelakun S, Ojewale A, Jeje S, Adedotun O. Histomorphometric and biochemical activities of bioactive component of Cyperus esculentus Tubers extract on letrozole-induced polycystic ovarian syndrome and cholesterol homeostasis in female Sprague-Dawley rats. Toxicol Res Appl 2022; 1:1-18.

[19] Kamble AV, Dhamane SP, Kulkarni AS, Potnis VV. Review on effects of herbal extract for the treatment of polycystic ovarian syndrome (PCOS). Plant Arch 2020; 20(1):1189-1195.

[20] Pachiappan S, Ramalingam K, Balasubramanian A. A review on phytomedicine and their mechanism of action on PCOS. Int J Current Res Rev 2020; 12(23):81-90.

[21] Londe P, Agrwal S. In vitro phytochemical study on Berberis aristata root extracts: An effective neutraceutical for the treatment of polycystic ovarian syndrome (PCOS). Int J Recent Sci Res 2017; 8(9):19934199340.

[22] Kabra A, Martins N, Sharma R, Kabra R, Baghel US. Myrica esculenta Buch.-Ham. ex D. Don: A natural source for health promotion and disease prevention. Plants 2009; 8(6):149.

[23] Kamat S, Barde P, Raut S. Evaluation of the estrogenic activity of Indian medicinal plants in immature rats. Anc Sci Life 2015; 35(2):90-95.

[24] Shailajan S, Sayed N, Tiwari B. Evaluation of the impact of regional variation on β-sitosterol content in Asteracantha longifolia Nees. seeds using HPTLC and HPLC technique. Pharmacog Commun 2013; 4(1):103-107.

[25] Swar G, Shailajan S, Menon S. Activity based evaluation of a tradtional Ayurvedic medicinal plant: Saraca asoca Roxb. de Wilde flowers as estrogenic agents using overiectomized rat model. J Ethnopharmacol 2017; 4(195):324-333.

[26] Kamalakkannan N, Prince PSM. Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats. J Ethnopharmacol 2003; 87(2-3):207-210.

[27] Bhutkar MA, Bhinge SD, Randive DS, Wadkar GH. Hypoglycemic effects of Berberis aristata and Tamarindus indica extracts in vitro. Bull Fac Pharm Cairo Univ 2017; 55(1):91-94.

[28] Khushalani H, Tatke P, Singh KK. Antifertility activity of dried flowers of Woodfordia fruticosa kurz. Indian J Pharm Sci 2006; 68:528-529.

[29] Lal B, Udupa KN. A preliminary study of antifertility effect of an indigenous drug--arjuna (Terminalia arjuna W. & A.). J Res Ayurveda Siddha 1993; 14(4):165-169.

[30] Bigoniya P, Singh CS. Hepatoprotective activity of a standardized polyherbal liver formulation. Int J Pharm Sci Res 2014; 5(10):4209-4218.

[31] Chandrashekhar R, Bakshi V, Jeripothula J, Nelavelli LB, Bhavani R. Protective and therapeutic effect of protocatechuic acid in assessment of letrozole induced polycystic ovary syndrome in rats. Asian Pac J Reprod 2020; 9(5):230-238.

[32] Anand P, Yanda M, Tandon V, Chandra R. Preliminary studies on antihyperglycemic effect of aqueous extract of Brassica nigra (L.) Koch in streptozotocin induced diabetic rats. Indian J Exp Biol 2007; 45(8):693-701.

[33] Saraswathi CD, Gupta SK, Sreemantula S. Protective effect of Symplocos racemosa bark on cold restraint stress induced reproductive changes in female rats. J Nat Prod 2012; 5:251-258.

[34] Jahan S, Abid A, Khalid S, Afsar T, Ain Q, Shaheen G, et al. Therapeutic potentials of quercetin in management of polycystic ovarian syndrome using letrozole induced rat model: A histological and a biochemical study. J Ovarian Res 2018; 11:26.

[35] Prajapati D, Patel M, Dharamsi A. Benefical effect of polyherbal formulation in letrozole indcued polycystic ovarian syndrome (PCOS). J Tradit Complement Med 2022; 12(6):575-583. doi: 10.1016/j.jtcme.2022.08.003.

[36] Mostafa RA, Al-Sherbeeny MM, Abdelazim IA, Khalifa AA, Fahmy AA, Ahmed N. Free testosterone and dehydroepiandrosterone sulfate serum levels in polycystic ovary syndrome women. J Adv Med Sci Appi Technol 2017; 3(1):17-20. doi: 10.18869/nrip.jamsat.3.1.17.

[37] Ndeingang E, Defo Deeh P, Watcho P, Kamanyi A. Phyllanthus muellerianus (Euphorbiaceae) restores ovarian functions in letrozole-induced polycystic ovarian syndrome in rats. Evid Based Complement Alternat Med 2019; 2019:2965821. doi: 10.1155/2019/2965821.

[38] Kandasamy S, Ivagamasundari RI, Bupathy A, Sethubathy S, Gobal V. Evaluation of insulin resistance and oxidative stress in obese patients with polycystic ovary syndrome. Int J Appl Biol Pharm Technol 2010; 2:391-398.

[39] Zhang D, Luo WY, Liao H, Wang CF, Sun Y. The effects of oxidative stress to PCOS. Sichuan Da Xue Xue Bao Yi Xue Ban 2008; 39(3):421423.

[40] Olufisayo GO, Modupe FA. Assessment of antioxidant status of women with polycystic ovarian syndrome. Asian Pac J Reprod 2020; 9(1):9-15.

[41] Mohan SK, Vishnu PV. Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. Bio Med 2009; 1:44-49.

[42] Fatima Q, Amin S, Kawa IA, Jeelani H, Manzoor S, Rizvi SM, et al. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diabetes Metab Syndr 2019; 13(3):1957-1961. doi: 10.1016/j.dsx.2019.04.032.

[43] Mehraban M, Jelodar G, Rahmanifar F. A comnination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS. J Ovarian Res 2020; 13(1):32. doi: 10.1186/s13048-020-00633-8.

[44] Çelik LS, Kuyucu Y, Yenilmez ED, Tuli A, Dağlioğlu K, Mete UÖ. Effects of vitamin D on ovary in DHEA treated PCOS rat model: A light and electron microscopic study. Ultrastruct Pathol 2018; 42(1):55-64. doi: 10.1080/01913123.2017.1385668.